Last updated on December 2019

A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Moderate to Severe Crohn's Disease


Brief description of study

The purpose of this study is to evaluate the potential effects of an intravenous (IV) induction and subcutaneous (SC) maintenance administration of ustekinumab on the pharmacokinetic (PK) of a cocktail of representative probe substrates of cytochrome P450 (CYP) enzymes (CYP3A4, CYP2C9, CYP2C19, CYP2D6, and CYP1A2) in participants with moderate to severe Crohn's disease (CD).

Clinical Study Identifier: NCT03358706

Find a site near you

Start Over

WCCT Global, LLC

Cypress, CA United States
  Connect »

Accel Research Sites

DeLand, FL United States
  Connect »

Advanced Pharma CR, LLC

Miami, FL United States
  Connect »

Duke University

Durham, NC United States
  Connect »

University of Washington

Seattle, WA United States
  Connect »

Akh Wien

Wien, Austria
  Connect »

Az Sint-Maarten

Mechelen, Belgium
  Connect »

Wythenshawe Hospital

Greater Manchester, United Kingdom
  Connect »

Guy's Hospital

London, United Kingdom
  Connect »

Immunoe Research Centers

Centennial, CO United States
  Connect »

University Of Minnesota

Minneapolis, MN United States
  Connect »